DarshanTalks Podcast

A podcast by Darshan Kulkarni

406 Episoade

Anti-Kickback Settlement Surge
Publicat: 20.08.2019
Insys & Mallinckrodt: Is Legal Really Necessary on Your Promotional Review Teams?
Publicat: 15.08.2019
Alzheimer’s and Snake Oil Salesmen
Publicat: 13.08.2019
Stem Cell Clinics
Publicat: 13.08.2019
Responding to an FDA Inspection – Part 3 (Preparing a War Room)
Publicat: 08.08.2019
Responding to an FDA Inspection – Part 4 (Preparing a War Room)
Publicat: 08.08.2019
Responding to an FDA Inspection – Part 2 (FDA Findings, What the FDA Can Do)
Publicat: 08.08.2019
Responding to an FDA Inspection – Part 1 (FDA Findings, What the FDA Can Do)
Publicat: 08.08.2019
Diving Deeper Into Understanding Bioethics
Publicat: 08.08.2019
10 Ways to Communicate With the FDA
Publicat: 01.08.2019
FDA and Vaping: Influencer Marketing Warning
Publicat: 23.07.2019
Types of Ethics
Publicat: 20.07.2019
ENDS Product Marketing: FDA releases guidance on marketing vaping products
Publicat: 16.07.2019
23&me and Ethical Engagement
Publicat: 11.07.2019
FDA Warning Letter: Vivus
Publicat: 11.07.2019
Government Shutdowns & Patient Centricity
Publicat: 06.06.2019
CBD: FDA Hearing
Publicat: 31.05.2019
Minimizing Participant Loss in Clinical Trials – Part 2
Publicat: 30.05.2019
Minimizing Participant Loss in Clinical Trials – Part 1
Publicat: 23.05.2019
Why Patients Aren’t Joining Your Clinical Trial – Part 2
Publicat: 16.05.2019

20 / 21

Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do. We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.

Visit the podcast's native language site

406 Episoade

Anti-Kickback Settlement Surge

Insys & Mallinckrodt: Is Legal Really Necessary on Your Promotional Review Teams?

Alzheimer’s and Snake Oil Salesmen

Stem Cell Clinics

Responding to an FDA Inspection – Part 3 (Preparing a War Room)

Responding to an FDA Inspection – Part 4 (Preparing a War Room)

Responding to an FDA Inspection – Part 2 (FDA Findings, What the FDA Can Do)

Responding to an FDA Inspection – Part 1 (FDA Findings, What the FDA Can Do)

Diving Deeper Into Understanding Bioethics

10 Ways to Communicate With the FDA

FDA and Vaping: Influencer Marketing Warning

Types of Ethics

ENDS Product Marketing: FDA releases guidance on marketing vaping products

23&me and Ethical Engagement

FDA Warning Letter: Vivus

Government Shutdowns & Patient Centricity

CBD: FDA Hearing

Minimizing Participant Loss in Clinical Trials – Part 2

Minimizing Participant Loss in Clinical Trials – Part 1

Why Patients Aren’t Joining Your Clinical Trial – Part 2